Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2023 Earnings Call Transcript


Fisher & Paykel Healthcare Corporation Limited (OTCPK:FSPKF) Q4 2023 Earnings Conference Call May 25, 2023 6:00 PM ET

Company Participants

Marcus Driller – Vice President of Corporate

Lewis Gradon – Managing Director and Chief Executive Officer

Lyndal York – Chief Financial Officer

Paul Shearer – Senior Vice President of Sales and Marketing

Andrew Somervell – Vice President of Products and Technology

Conference Call Participants

Gretel Janu – Credit Suisse AG

David Low – JPMorgan Chase & Co.

Matt Montgomerie – Forsyth Barr Group Ltd.

Craig Wong-Pan – RBC Capital Markets

Dan Hurren – MST Marquee

Tom Deacon – Macquarie

Saul Hadassin – Barrenjoey Markets

Stephen Ridgewell – Craigs Investment Partners

Marcus Curley – UBS

Sean Laaman – Morgan Stanley

Adrian Allbon – Jarden Limited

Mathieu Chevrier – Citigroup Inc.

Chris Cooper – Goldman Sachs


Welcome to the Fisher & Paykel Healthcare’s Results Conference Call. My name is Cynthia, and I will be your operator for today’s call. At this time, everyone except the guest speakers’ will be in a listen-only mode. Later, we will conduct a question-and-answer session. We ask for your assistance in keeping the call to a maximum of one hour. [Operator Instructions] Please note this conference call is being recorded.

I would now like to turn the call over to Marcus Driller, VP Corporate. Please go ahead.

Marcus Driller

Thank you, Cynthia. Good morning, everyone, and welcome to Fisher & Paykel Healthcare’s 2023 financial year results conference call.

On the call today are Lewis Gradon, our Managing Director and Chief Executive Officer; Lyndal York, Chief Financial Officer; Paul Shearer, Senior VP of Sales and Marketing; and Andrew Somervell, our VP of Products and Technology. Lewis and Lyndal will first provide an overview of the results, and then we’ll open up the call to questions for the team. We will be discussing our results for the year